Safety, Tolerability, and Pharmacokinetic Evaluation of Single and Multiple Doses of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Healthy Japanese and White Adults
暂无分享,去创建一个
[1] A. O'donnell,et al. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. , 2020, The New England journal of medicine.
[2] J. Elborn,et al. INVITED REVIEW SERIES: PAEDIATRIC AND ADULT BRONCHIECTASIS , 2018 .
[3] J. Chalmers,et al. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis , 2018, BMC Pulmonary Medicine.
[4] A. Jauhiainen,et al. Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects , 2018, Clinical pharmacology and therapeutics.
[5] F. Blasi,et al. Neutrophil elastase in bronchiectasis , 2017, Respiratory Research.
[6] A. Jauhiainen,et al. Effect of CYP3A4 inhibitors verapamil and itraconazole on the pharmacokinetics of AZD7986, an oral DPP1 inhibitor , 2017 .
[7] T. Welte,et al. European Respiratory Society guidelines for the management of adult bronchiectasis , 2017, European Respiratory Journal.
[8] D. Weycker,et al. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013 , 2017, Chronic respiratory disease.
[9] S. Connolly,et al. Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). , 2016, Journal of medicinal chemistry.
[10] W. Guan,et al. Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations , 2015, Respiratory Care.
[11] M. Horwitz,et al. Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.
[12] L. Dupont,et al. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century , 2010, Postgraduate Medical Journal.
[13] L Zhang,et al. The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies , 2008, Clinical pharmacology and therapeutics.
[14] Christine T. N. Pham,et al. Neutrophil serine proteases: specific regulators of inflammation , 2006, Nature Reviews Immunology.